PRISM BioLab Co.,LTD (TYO:206A)
83.00
-1.00 (-1.19%)
Nov 18, 2026, 11:09 AM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 3.07 billion as of November 17, 2026. It is the 36,245th most valuable company in the world and the 3,332nd biggest in Japan. Its market cap has decreased by 58.53% in one year.
Market Cap
3.07B
Enterprise Value
1.23B
Revenue
518.00M
Global Rank
Country Rank
#3,332 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 3.07B, a decrease of -82.80%. That is a compound annual growth rate of -52.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 3.07B | -46.73% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MEDINET | 4.84B |
| Kringle Pharma | 4.43B |
| SUSMED,Inc. | 4.27B |
| Noile-Immune Biotech | 3.52B |
| Chordia Therapeutics | 3.40B |
| Kohjin Bio | 3.34B |
| Modalis Therapeutics | 3.30B |
| Transgenic Group | 3.28B |